Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]        
Revenues $ 2,902,000 $ 4,936,000 $ 10,330,000 $ 16,472,000
Cost of revenues 1,699,000 2,941,000 6,433,000 9,719,000
Gross profit 1,203,000 1,995,000 3,897,000 6,753,000
Operating expenses        
Research and development 26,000 33,000 121,000 425,000
Selling, general and administrative 2,135,000 2,100,000 6,603,000 6,963,000
Total operating expenses 2,161,000 2,133,000 6,724,000 7,388,000
Loss from operations (958,000) (138,000) (2,827,000) (635,000)
Interest income (expense), net 3,000 (2,000) (1,000) 2,000
Other income (expense), net 11,000 (490,000) 542,000 (687,000)
Gain on sale of assets 0 4,000 150,000 137,000
Loss from continuing operations (944,000) (626,000) (2,136,000) (1,183,000)
Income tax expense 0 0 (6,000) 0
Income (loss) from discontinued operations (Note 4) 0 (24,000) 0 893,000
Net loss $ (944,000) $ (650,000) $ (2,142,000) $ (290,000)
Net income (loss) per share: basic        
Continuing operations $ (0.31) $ (0.31) $ (0.85) $ (0.60)
Discontinued operations 0 (0.01) 0 0.45
Total basic net income (loss) per share (0.31) (0.32) (0.85) (0.15)
Net income (loss) per share: diluted        
Continuing operations (0.31) (0.31) (0.85) (0.60)
Total diluted net income (loss) per share $ (0.31) $ (0.32) $ (0.85) $ (0.15)
Weighted-average number of shares used in per common share calculations: basic 3,080 2,052 2,507 1,967
Weighted-average number of shares used in per common share calculations: diluted 3,080 2,052 2,507 1,967
Other comprehensive income (loss)        
Foreign currency translation adjustments $ (65,000) $ 1,020,000 $ 8,000 $ 1,375,000
Comprehensive income (loss) $ (1,009,000) $ 370,000 $ (2,134,000) $ 1,085,000